It wasn't exactly business as usual Wednesday at Affymetrix Inc., which struck separate financial and product development deals announced hours apart. (BioWorld Today)

Affymetrix Enters Deal With NuGEN, Prices $100M Notes

Dec. 11, 2003

By Aaron Lorenzo

No Comments

It wasn't exactly business as usual Wednesday at Affymetrix Inc., which struck separate financial and product development deals announced hours apart. (BioWorld Today)

Kosan Adds $28M In Stock Sale To Support Early Clinical Work

Dec. 11, 2003

By Aaron Lorenzo

No Comments

Cancer Diagnostics Company Immunicon Joins IPO Queue

Dec. 10, 2003

By Aaron Lorenzo

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Articles by Aaron Lorenzo

FDA Receives Supplemental NDA For Fuzeon From Trimeris, Roche

Trying Again: Idenix Files For Another Initial Public Offering

Trying Again: Idenix Files For Another Initial Public Offering

VasGene Uses ASH Platform To Tout Anti-VEGF Cancer Product

VasGene Uses ASH Platform To Tout Anti-VEGF Cancer Product

Kosan Adds $28M In Stock Sale To Support Early Clinical Work

Affymetrix Enters Deal With NuGEN, Prices $100M Notes

Affymetrix Enters Deal With NuGEN, Prices $100M Notes

Kosan Adds $28M In Stock Sale To Support Early Clinical Work

Cancer Diagnostics Company Immunicon Joins IPO Queue

Today's news in brief

Today's news in brief

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

Australia’s Celosia heads toward clinic with gene therapy for ALS

Sangamo stock plunges as Pfizer leaves hemophilia partnership